The Coronavirus Vaccine, cataloged under National Stock Number 6505-01-734-5670, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Moderna Us, Inc.. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-734-5670 |
| Primary Part Number | NDC80777-0400-60 |
| Item Name | Coronavirus Vaccine |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Moderna Us, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 0.2 MILLILITERS |
| Virus Strain | COVID-19 |
| Primary Container Type | SYRINGE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC80777-0400-60 PRIMARY | Moderna Us, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1709474 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM252107 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-734-5670 is a Coronavirus Vaccine, manufactured by Moderna Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-734-5670 has 1 manufacturer part number on file: NDC80777-0400-60 (Moderna Us, Inc.).
Key specifications for NDC80777-0400-60: Primary Container Content Quantity: 0.2 MILLILITERS; Virus Strain: COVID-19; Primary Container Type: SYRINGE; Special Features: INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2). APPROVED FOR USE IN INDIVIDUALS 65 YEARS AND OLDER OR 12 YEARS THROUGH 64 YEARS OF AGE WITH AT LEAST ONE UNDERLYING THAT PUTS THEM AT HIGH RISK FOR SEVERE OUTCOMES FROM COVID-19. INJECTABLE SUSPENSION, FOR INTRAMUSCULAR USE; BOX OF 10 SINGLE DOSE PRE-FILLED SYRINGES, EACH SYRINGE CONTAINING 1 DOSE OF 0.2ML; STORE FROZEN BETWEEN -40 C TO -15 C (-40 F TO 5 F). AFTER THAWING, MAY BE STORED REFRIGERATED BETWEEN 2 C TO 8 C (36 F TO 46 F) FOR UP TO 90 DAYS OR UP TO THE EXPIRATION DATE PRINTED ON THE BOX, WHICHEVER COMES FIRST. MINIMIZE EXPOSURE TO ROOM LIGHT, AND AVOID EXPOSURE TO DIRECT SUNLIGHT AND ULTRAVIOLET LIGHT. DO NOT REFREEZE ONCE THAWED. 2025-2026 FORMULA.. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.